Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.160.16NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.4.16 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.1.22NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.70NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.42NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.428NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.374NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.63 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.377NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.258.15NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.298NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.30.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.76NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.258.11NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.160.31NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.385NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.384NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.160.32NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.357NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BP.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.46NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.3.21NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
A.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.530NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.75.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CH.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.570NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.633NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DD.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.136NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XAYNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DJ.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XAENYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.467NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.484NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.476NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
A.19NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
A.18NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.404NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CV.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DJ.1.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.73NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DW.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BR.5.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.75.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XAKNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XAANYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.501NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.226NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used